Irhythm Technologies (IRTC) and Avinger (AVGR) Head to Head Analysis

Irhythm Technologies (NASDAQ:IRTC) and Avinger (NASDAQ:AVGR) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their risk, valuation, analyst recommendations, dividends, earnings, institutional ownership and profitability.


This table compares Irhythm Technologies and Avinger’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Irhythm Technologies -34.38% -53.59% -32.15%
Avinger -477.76% N/A -178.69%

Valuation & Earnings

This table compares Irhythm Technologies and Avinger’s gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Irhythm Technologies $98.51 million 18.78 -$29.42 million ($1.30) -59.43
Avinger $9.93 million 0.38 -$48.73 million ($70.07) 0.00

Irhythm Technologies has higher revenue and earnings than Avinger. Irhythm Technologies is trading at a lower price-to-earnings ratio than Avinger, indicating that it is currently the more affordable of the two stocks.

Institutional & Insider Ownership

1.5% of Avinger shares are owned by institutional investors. 5.1% of Irhythm Technologies shares are owned by company insiders. Comparatively, 1.5% of Avinger shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Volatility & Risk

Irhythm Technologies has a beta of 1.34, suggesting that its stock price is 34% more volatile than the S&P 500. Comparatively, Avinger has a beta of 0.85, suggesting that its stock price is 15% less volatile than the S&P 500.

Analyst Ratings

This is a breakdown of recent recommendations for Irhythm Technologies and Avinger, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Irhythm Technologies 0 3 6 0 2.67
Avinger 0 0 1 0 3.00

Irhythm Technologies presently has a consensus target price of $94.14, indicating a potential upside of 21.85%. Given Irhythm Technologies’ higher possible upside, equities analysts plainly believe Irhythm Technologies is more favorable than Avinger.


Irhythm Technologies beats Avinger on 10 of the 14 factors compared between the two stocks.

Irhythm Technologies Company Profile

iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. The company offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. Its Zio XT monitor, a single-use, wire-free, and wearable patch-based biosensor, records patient's heartbeats and ECG data. The company was founded in 2006 and is headquartered in San Francisco, California.

Avinger Company Profile

Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells image-guided and catheter-based systems used by physicians to treat patients with peripheral arterial disease (PAD) in the United States and Europe. It develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures. The company's lumivascular products comprise Lightbox imaging consoles, as well as the Ocelot family of catheters, which are designed to penetrate a total blockage in an artery; and Pantheris, an image-guided atherectomy device that allows physicians to precisely remove arterial plaque in PAD patients. In addition, its first-generation chronic total occlusion (CTO)-crossing catheters, Wildcat, and Kittycat 2, which employs a proprietary design that uses a rotational spinning technique allowing the physician to switch between passive and active modes when navigating across a CTO. The company sells and markets its products to interventional cardiologists, vascular surgeons, and interventional radiologists. Avinger, Inc. was founded in 2007 and is headquartered in Redwood City, California.

Receive News & Ratings for Irhythm Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Irhythm Technologies and related companies with's FREE daily email newsletter.

Leave a Reply